Radiopharm Theranostics Limited current ratio

The Current Ratio as of November 2026 (TTM) for Radiopharm Theranostics Limited (RADX) is 1.16

According to Radiopharm Theranostics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.16. This represents a change of -54.56% compared to the average of 2.55 of the last 4 quarters.

Radiopharm Theranostics Limited (RADX) Historical Current Ratio (quarterly & annually)

How has RADX Current Ratio performed in the past?

The mean historical Current Ratio of Radiopharm Theranostics Limited over the last ten years is 1.67. The current 1.16 Current Ratio has changed -30.61% with respect to the historical average. Over the past ten years (40 quarters), RADX's Current Ratio was at its highest in in the December 2021 quarter at 5.34. The Current Ratio was at its lowest in in the December 2020 quarter at 0.

Radiopharm Theranostics Limited (RADX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Radiopharm Theranostics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Radiopharm Theranostics Limited (RADX) Average Current Ratio

How has RADX Current Ratio performed in the past?

The current Current Ratio of Radiopharm Theranostics Limited (RADX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Radiopharm Theranostics Limited (RADX) Current Ratio vs. Peers

How is RADX’s Current Ratio compared to its peers?

Radiopharm Theranostics Limited’s Current Ratio is greater than Alaunos Therapeutics, Inc. (0.77), greater than Impact BioMedical Inc. (0.16), less than Quoin Pharmaceuticals, Ltd. (1.76), less than NovaBay Pharmaceuticals, Inc. (17.20), greater than Brainstorm Cell Therapeutics Inc. (0.03), less than Cardio Diagnostics Holdings, Inc. (17.15), greater than Addex Therapeutics Ltd (0.76), greater than Matinas BioPharma Holdings, Inc. (0.85), less than Pasithea Therapeutics Corp. (26.25), greater than Cyclerion Therapeutics, Inc. (0.82),

Build a custom stock screener for Radiopharm Theranostics Limited (RADX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Radiopharm Theranostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Radiopharm Theranostics Limited (RADX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Radiopharm Theranostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.